Home › Funds › Rosalind Advisors, Inc. › AVIR

Rosalind Advisors, Inc. position in AVIR

ATEA PHARMACEUTICALS INC · Health Care

Rosalind Advisors, Inc. reported holding 1,070,550 shares of AVIR (ATEA PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$5.0M, representing 1.85% of its reported portfolio and ranking #16 among its reported holdings. Rosalind Advisors, Inc. has disclosed AVIR holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)1.07M sh
Reported value held$4.98M
Portfolio Weight1.85%
First reportedQ1 2026
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Rosalind Advisors, Inc.'s AVIR position evolved

Rosalind Advisors, Inc. first disclosed a stake in AVIR in Q1 2026 at 1,171,855 shares (US$6.3M). Across 2 filings, Rosalind Advisors, Inc. increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,070,550 shares valued at US$5.0M — a reduction of -101,305 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2026 1.17M $6.30M New
Q2 2026 1.07M $4.98M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AVIR and 13F data

AVIR (ATEA PHARMACEUTICALS INC) is a Health Care company. 31 other funds we track also report a position in AVIR — the largest reported positions include BML Capital Management, LLC (US$32.3M), TANG CAPITAL MANAGEMENT LLC (US$22.4M), Bain Capital Life Sciences Investors, LLC (US$9.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AVIR

All AVIR fund holders →

FAQ

How long has Rosalind Advisors, Inc. held AVIR?

Rosalind Advisors, Inc. has disclosed AVIR holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Rosalind Advisors, Inc.'s current position in AVIR?

As of Q2 2026, Rosalind Advisors, Inc. holds 1.07M shares of AVIR (ATEA PHARMACEUTICALS INC), valued at $4.98M, representing 1.85% of its reported portfolio and ranking #16.

Has Rosalind Advisors, Inc. been buying or selling AVIR?

In the latest 13F filing (Q2 2026), Rosalind Advisors, Inc. reduced its position in AVIR.

Which other funds hold AVIR?

Other major institutional holders of AVIR include BML Capital Management, LLC, TANG CAPITAL MANAGEMENT LLC, Bain Capital Life Sciences Investors, LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.